Men with germline BRCA1 or BRCA2 mutations have a three- to eight-fold higher lifetime risk of PCa that can behave aggressively because of additional MYC activation in combination with inactivation of TP53 and PTEN [52,53]. Here, BRCA2 is linked to posterior cortical atrophy.